Biodefense Market by Type and Application - Global Industry Analysis and Forecast To 2022

LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- The latest trending report published by Crystal Market Research titled, Biodefense Market, approximates that the Biodefense Market size is estimated to flourish at a significant CAGR in the future, and this is attributed to the escalation in need for this product across the globe along with novel innovations in the market.

In 2012, the global biodefense market was evaluated around USD 7.98 billion and is expected to reach approximately USD 16.16 billion by 2022 while registering itself at a compound annual growth rate (CAGR) of 7.32% over the forecast period owing to technological developments in pathogen detection method in the forensic department. A few of the modern technologies employed in biodefense are nanotechnology, database management systems, advanced detector hardware, and gene chips. The rising vaccines production, quick diagnostic procedures, superior detection and forensic therapies, and prophylactics are amongst the crucial factors anticipated to reinforce the biodefense capabilities around the globe over the projected period. Escalating investment by the local government in developed economies, like the Europe and the United States, for biodefense awareness, is expected to boost the growth during the forecast years. According to the report issued by the Centre for Research on Innovation and Science Policy, it was affirmed that the number of grants owed by the National Institutes of Health (NIH) for the progress of bioweapon agents, like anthrax, plague, ganders, brucellosis, and tularemia, had augmented by 15 times over the years, 1996-2001. Due to the augment in the number of co-owned and foreign-owned patents, a number of international associations, subcontracting, and technological collaboration agreements are increasing, which are hence anticipated to drive the market demand in the approaching few years.

Book Your Sample Copy of the Report here -

The report Biodefense Market render a wide-ranging analysis of the said market in terms of product, regional, application and end user segmentation. The report comprises of the present market size of this industry. Also, the potential outlooks and current market summary of this segment has been thoroughly analyzed in this report. Moreover, chief market players of the Biodefense Market are studied on various factors like product portfolio, company profile, sales analysis, revenue generation through the forecast period.

Major key Players

  • Xoma Corporation
  • PharmAthene Inc.
  • Emergent BioSolutions Inc.
  • Dynavax Technologies Corporation
  • SIGA Technologies Inc.
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems Inc.
  • DynPort Vaccine Company LLC
  • Cleveland BioLabs Inc.
  • Bavarian Nordic
  • Achaogen Inc.
  • Nanotherapeutics Inc.
  • Alnylam Pharmaceuticals Inc.

To Grab the Complete Report, Please Visit:

Table of Contents

  1. Introduction
    1.1. Report Description
    1.2. Research Methodology
          1.2.1. Secondary Research
          1.2.2. Primary Research
  2. Executive Summary
    2.1. Key Highlights
  3. Market Overview
    3.1. Introduction
           3.1.1. Market Definition
           3.1.2. Market Segmentation
    3.2. Market Dynamics
           3.2.1. Drivers
            Presence of Favorable Government Initiatives
            Emergency Use Authorization of Medical Products
           3.2.2. Restraints
            Low Penetration in Developing and Underdeveloped Countries
           3.2.3. Opportunities
            Emerging Markets to Offer Lucrative Growth Opportunities
  4. Biodefense Market, By Application
  5. Biodefense Market, By Region
  6. Company Profiles

Ask For Customization:

Report’s Magnitude:

This report contains Segment wise in-depth analysis in terms several above-mentioned segments along with market size forecasts and approximations to observe significant areas of industry growth in detail. Additionally, an executive summary, summarizing the entire report in such a way that decision-making team can speedily become familiar with background information, summarizing analysis and main conclusions.

Contact Us:

304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282